Related Experiment Video

Updated: May 25, 2026

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes
08:32

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes

Published on: May 23, 2025

The potential of exploiting DNA-repair defects for optimizing lung cancer treatment

Sophie Postel-Vinay1, Elsa Vanhecke, Ken A Olaussen

  • 1INSERM U981, Department of Medicine, Université Paris-Sud XI-Institut Gustave Roussy, 114 rue Edouard Vaillant, 94805 Villejuif, France.

Nature Reviews. Clinical Oncology
|February 15, 2012
PubMed

Insights

DNA repair mechanisms are crucial in non-small-cell lung cancer (NSCLC). Targeting DNA repair biomarkers can personalize platinum-based chemotherapy, improving patient outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Tumor genomes frequently exhibit aberrations due to DNA damage and impaired repair.
  • DNA repair is an emerging therapeutic target, offering novel strategies to enhance chemotherapy efficacy.
  • Non-small-cell lung cancer (NSCLC) treatment relies heavily on platinum-based chemotherapy, necessitating treatment optimization.

Purpose of the Study:

  • To explore the role of DNA repair pathways in NSCLC.
  • To investigate DNA repair biomarkers for predicting treatment response.
  • To discuss a molecular classification of NSCLC based on DNA repair for improved clinical decision-making.

Main Methods:

  • Review of current literature on DNA repair in cancer.
  • Analysis of DNA-repair biomarkers (ERCC1, BRCA1, RRM1) and their predictive value.
  • Discussion of germline variation in DNA-repair genes.

Main Results:

  • Specific DNA repair biomarkers can predict response to platinum, taxanes, and gemcitabine therapies in NSCLC.
  • Targeting DNA repair enzymes offers a mechanism-based approach to potentiate chemotherapy.
  • Germline variations in DNA repair genes may also provide predictive information.

Conclusions:

  • A molecular and functional classification of NSCLC based on DNA repair status can guide clinical decisions.
  • Personalizing NSCLC treatment using DNA repair biomarkers can potentially improve patient outcomes.
  • Further research into DNA repair mechanisms and biomarkers is essential for advancing NSCLC therapy.

More Related Videos

Using Next Generation Sequencing to Identify Mutations Associated with Repair of a CAS9-induced Double Strand Break Near the CD4 Promoter06:59

Using Next Generation Sequencing to Identify Mutations Associated with Repair of a CAS9-induced Double Strand Break Near the CD4 Promoter

Published on: March 31, 2022

Related Concept Videos

Nucleotide Excision Repair01:38

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair01:08

Nucleotide Excision Repair

Overview
Overview of DNA Repair02:25

Overview of DNA Repair

In order to be passed through generations, genomic DNA must be undamaged and error-free. However, every day, DNA in a cell undergoes several thousand to a million damaging events by natural causes and external factors. Ionizing radiation such as UV rays, free radicals produced during cellular respiration, and hydrolytic damage from metabolic reactions can alter the structure of DNA. Damages caused include single-base alteration, base dimerization, chain breaks, and cross-linkage.
Chemically...
Overview of DNA Repair02:25

Overview of DNA Repair

In order to be passed through generations, genomic DNA must be undamaged and error-free. However, every day, DNA in a cell undergoes several thousand to a million damaging events by natural causes and external factors. Ionizing radiation such as UV rays, free radicals produced during cellular respiration, and hydrolytic damage from metabolic reactions can alter the structure of DNA. Damages caused include single-base alteration, base dimerization, chain breaks, and cross-linkage.
Chemically...
Base Excision Repair01:54

Base Excision Repair

One of the common DNA damages is the chemical alteration of single bases by alkylation, oxidation, or deamination. The altered bases cause mispairing and strand breakage during replication. This type of damage causes minimal change to the DNA double helix structure and can be repaired by the base excision repair (BER) pathways. BER corrects damaged DNA sequences by removing the damaged base and restoring the original base sequence using the complementary strand as a template.
The first step of...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...